Trial Profile
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating The Efficacy And Safety of Maxacalcitol Ointment (22-Oxacalcitriol) In Patients With Palmoplantar Pustulosis (PPP).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Mar 2017
Price :
$35
*
At a glance
- Drugs Maxacalcitol (Primary)
- Indications Palmoplantar pustulosis
- Focus Therapeutic Use
- 15 Mar 2017 New trial record